dept header
Directory | Contact
Bernard K. Crawford, MD

image: Bernard K. Crawford, MD
Dr. Bernard K. Crawford

Bernard K. Crawford is Assistant Professor of Cardiothoracic Surgery at NYU School of Medicine, and the Director of General Thoracic Surgery at Tisch Hospital.

Dr. Crawford specializes in the treatment of general thoracic surgical conditions including lung cancer, mediastinal tumors, chest wall tumors and other general thoracic surgical conditions. He utilizes minimally invasive surgical techniques to perform virtually all of his surgical interventions. He is board certified by the American Board of Surgery and the American Board of Thoracic Surgery.

Dr. Crawford attended Wesleyan University and George Washington University Medical School where he graduated with distinction and was elected to AOA. He completed his internship, residency and chief residency training in general surgery at NYU Medical Center, where he continued his specialty training and completed a fellowship in cardiac and thoracic surgery. He then joined the NYU faculty and performed and taught open heart surgery and general thoracic surgical procedures for the next nine years before limiting his practice to general thoracic surgery in 1997. He continues to teach medical students, residents and fellows the techniques of thoracic surgery.

For the past fifteen years Dr. Crawford has been instrumental in expanding the use of minimally invasive techniques to treat most general thoracic surgical conditions. He assists orthopedic surgeons and neurosurgeons in performing complex spinal interventions. He has authored textbook chapters on such diverse topics as the surgical treatment of tuberculosis and techniques of exposure for spinal corrective surgery. He has presented original clinical research at major thoracic surgical meetings.

Dr. Crawford's primary focus remains as the diagnosis, treatment and investigation of the cause of lung cancer. He has collaborated with the NYU Division of Pulmonary and Critical Care Medicine and the NYU Cancer Institute by providing thoracic tumors under approved protocols. By doing so, multiple NYU basic science research colleagues will have the necessary material to study why lung cancers develop and how to treat them more effectively.